Vconf Suite Released
Release of VConf Suite for conformational search and analysis of drug-like molecules.
Release of VConf Suite for conformational search and analysis of drug-like molecules.
VeraChem makes fully functional versions of all software free for academic institutions.
NIH awards Phase II of fast-track SBIR for calculation of accurate ligand-protein affinities.
VeraChem has been awarded a patent for its novel molecular modeling user interface approach “Tailored user interfaces for molecular modeling”. USPTO 69,707,91.
VeraChem awarded fast-track SBIR to develop software for calculating accurate ligand-protein affinities. “Software for Accurate Ligand-Protein Affinities”
UMBI: Spin-Out Company Creates and Launches New Scientific Software to Aid in Drug Design (pdf) (verachem-umbi-publicity-10-2004.pdf)
Medical News Today: Intellectual Property Used to Create Scientific Software to Aid in Drug Design (http://www.medicalnewstoday.com/medicalnews.php?newsid=13689)
Washington Business Journal: VeraChem releases UMBI-licensed software (http://www.bizjournals.com/washington/stories/2004/08/30/daily28.html)
UMBI: VeraChem LLC To Speed Drug Discovery (http://www.umbi.umd.edu/nande/news/archive/02/061002_verachem.html)
VeraChem’s state of the art computational chemistry software is capable of protein-ligand and host-guest binding affinity prediction, fast calculation of accurate partial atomic charges for drug-like compounds, computation of energies and forces with empirical force fields, automatic generation of alternate resonance forms of drug-like compounds, conformational search with the powerful Tork distort-minimize algorithm, and automatic detection of topological and 3D molecular symmetries.
VeraChem LLC
12850 Middlebrook Rd Ste 205
Germantown
MD 20874-5244
Voice: 240-686-0565
Fax: 240-686-0564
General e-mail:
vc@verachem.com
Commercial licensing:
sales@verachem.com
Customer support:
support@verachem.com